Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
Impact of total retrieved lymph nodes on staging and survival of patients with gastric cancer invading the subserosa
Surgical Oncology, 11/05/09
Liu C et al. – To improve the accuracy of staging, no less than 15 tLNs should be pathologically examined in patients with pN1–3, and 25 tLNs for the patients with N0. More tLNs may not be associated with a better prognosis in pT2b disease because the extent of lymph node dissection is pre–defined for the operation.
Related Articles
Cimiside E arrests cell cycle and induces cell apoptosis in gastric cancer cells
Archives of Pharmacal Research, 11/17/09
Relevance Score: 87%
Capecitabine treatment patterns in patients with gastroesophageal cancer in the United States
World Journal of Gastroenterology, 10/06/09
Relevance Score: 87%
Early Gastric Cancer: Clinical Characteristics and Results of Surgery
Digestive Surgery, 11/13/09
Relevance Score: 86%
Docetaxel: its role in current and future treatments for advanced gastric cancer
Gastric Cancer, 11/11/09
Relevance Score: 86%
Gastric cancer mortality trends in Spain, 1976-2005: differences by autonomous region and sex
BMC Cancer, 10/09/09
Relevance Score: 86%
Today in GI Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Angiogenesis Soluble Factors as Hepatocellular Carcinoma Noninvasive Markers for Monitoring Hepatitis C Virus Cirrhotic Patients Awaiting Liver Transplantation
Transplantation, 11/25/09
A Rare Case of Giant Solitary Fibrous Tumor of the Esophagus
Annals of Thoracic Surgery, 11/24/09
Preoperative tumor marker doubling time is a useful predictor of recurrence and prognosis after hepatic resection of hepatocellular carcinoma
Journal of Surgical Oncology, 11/24/09
Sponsor
Article Search
Sponsor


See Latest Articles


